DG

Dayaldas Gagalram Menda

Active Director Designated Partner DIN 11661982
DIN 11661982 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Dayaldas Gagalram Menda

Data last updated:

Dayaldas Gagalram Menda is a Designated Partner at Dungrow Global Llp (since 2026) and Director at Velvion Pharmaceutical Private Limited (since 2026).

DIN 11661982
Primary Designation Designated Partner
First Appointment 13 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Jul 20262026Active
Director13 Apr 20262026Active

Board colleagues of Dayaldas Gagalram Menda

Directorship timeline

Open interactive timeline →
Velvion Pharmaceutical Private Limited
Dungrow Global Llp
Premium access

Shareholding and investment profile for Dayaldas Gagalram Menda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dayaldas Gagalram Menda

Dayaldas Gagalram Menda currently holds 2 directorships: Dungrow Global Llp (Designated Partner, since 08 Jul 2026); Velvion Pharmaceutical Private Limited (Director, since 13 Apr 2026).

Dayaldas Gagalram Menda was first appointed on 13 Apr 2026 as Director at Velvion Pharmaceutical Private Limited.

The current boards of Dayaldas Gagalram Menda's companies include Jaikishan Lalchand Sajnani (Dungrow Global Llp), Rachit Deepakkumar Devaliya (Dungrow Global Llp), Harshmeetsingh Satpalsingh Gurudutt (Velvion Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available